Clinical trials
Observational Pulmonary Embolism trials in France
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
62 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 1 |
| 2007 | 3 |
| 2008 | 2 |
| 2009 | 3 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 6 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 6 |
| 2019 | 6 |
| 2020 | 6 |
| 2021 | 5 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 4 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 42 |
| Unknown status | 10 |
| Recruiting | 5 |
| Terminated | 5 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| University Hospital, Brest | 8 |
| University Hospital, Strasbourg, France | 7 |
| Centre Hospitalier Universitaire de Saint Etienne | 5 |
| Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer | 3 |
| Centre Hospitalier Universitaire de Nīmes | 3 |
| Diagnostica Stago R&D | 3 |
| University Hospital, Angers | 3 |
| Assistance Publique - Hôpitaux de Paris | 2 |
| Bayer | 2 |
| Centre Hospitalier Universitaire de Nice | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Pulmonary Embolism | 62 |
| Venous Thrombosis | 24 |
| Venous Thromboembolism | 12 |
| COVID-19 | 4 |
| Thrombosis | 4 |
| Dyspnea | 3 |
| Foramen Ovale, Patent | 3 |
| Neoplasms | 3 |
| Recurrence | 3 |
| Stroke | 3 |
Trials
Showing 1 to 25 of 62. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.